Clinical Trial: A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07128550) titled 'A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide' on Aug. 13.

Brief Summary: This is a multicenter, open label, randomized Phase 3 clinical study to evaluate tobevibart + elebsiran in participants with Chronic HDV Infection not virologically suppressed with bulevirtide

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Viral Hepatitis

Intervention: DRUG: Tobevibart

Tobevibart administered by subcutaneous injection

DRUG: Elebsiran

Elebsiran administered by subcutaneous injection

DRUG: Bulevirtide

Bulevirtide administered by subcut...